From the Research
Endoluten Protocol Overview
The Endoluten protocol, also known as the Pineal gland peptide protocol, is a treatment approach that utilizes peptides to regulate and restore the function of the pineal gland. The protocol typically involves the administration of Epithalamin, a peptide bioregulator extracted from the pineal gland, to promote the normalization of basic bodily functions, including the cardiovascular, endocrine, immune, and nervous systems.
Key Findings
- A study published in 2003 1 demonstrated the geroprotective effects of Epithalamin in combination with Thymalin, a thymic peptide bioregulator, in elderly and older individuals, resulting in improved health outcomes and reduced mortality rates.
- The optimal dosage and administration protocol for peptide therapy may vary depending on the specific condition being treated and the individual patient's needs, as highlighted in a 2021 study on peptide receptor radionuclide therapy 2.
- The oral delivery of peptides and proteins is a challenging task due to poor bioavailability and stability, but current research is focused on developing strategies to enhance their stability and bioavailability, such as the use of absorption enhancers or carriers, structural modification, and advanced technology 3.
Administration and Dosage
- The administration protocol for Endoluten may involve periodic injections or oral administration, with the dosage and frequency of administration tailored to the individual patient's needs.
- A 2020 study on dosimetry after peptide receptor radionuclide therapy highlighted the importance of precise calculation of radiation-absorbed doses to tumors and normal organs, and the potential for reduced dosimetry protocols to improve patient comfort and reduce scanner and staff time 4.
- In cases where doses are delayed or missed, remedial strategies can be developed using pharmacometric modeling and simulation to establish the optimum dosing regimen and minimize unintended clinical consequences 5.